Our Team
At Perella Weinberg, we have a team of partners and professionals who bring leadership, influence, and experience across a wide range of industries.
Anthony Hartley
Dr. Anthony Hartley is a Partner at Perella Weinberg. Based in London, Dr. Hartley serves as an advisor to European healthcare companies. Prior to joining Perella Weinberg, Dr. Hartley was a Partner at Gleacher Shacklock.
Dr. Hartley has over 25 years of investment banking experience advising major European healthcare companies on a range of strategic, financial and M&A transactions across the pharmaceutical, biotechnology, generics and consumer health sectors. Representative transactions include advising GSK on their Consumer Health JV with Pfizer and its subsequent spin-off to form Haleon, Roche on its stake buy-back from Novartis, Bain & Cinven on their acquisition of Stada Arzneimittel, Hikma on their acquisition of Roxane generics from Boehringer Ingelheim, Bayer on the sale of their Dr. Scholls franchise to Yellow Wood Partners and Coppertone franchise to Beiersdorf, Johnson Matthey on the sale of its healthcare division to Altaris Capital, and Morningside on its sale to Aspire Pharmaceuticals.
Prior to joining Gleacher Shacklock, Dr. Hartley was EMEA Head of Healthcare Investment Banking at Citi, before which he worked at UBS as Head of European Pharmaceuticals having joined from Morgan Stanley. Prior to investment banking, Dr. Hartley held a variety of research and operational roles at Pfizer, GSK and AstraZeneca.
Dr. Hartley has a D.Phil in Pharmacology from Oxford University and an MBA with Distinction from Manchester Business School.